Viscofan (VIS) - Total Liabilities
Based on the latest financial reports, Viscofan (VIS) has total liabilities worth €573.61 Million EUR (≈ $670.61 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Viscofan - Total Liabilities Trend (2000–2025)
This chart illustrates how Viscofan's total liabilities have evolved over time, based on quarterly financial data. See VIS working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Viscofan Competitors by Total Liabilities
The table below lists competitors of Viscofan ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ArcBest Corp
NASDAQ:ARCB
|
USA | $1.17 Billion |
|
Vidrala SA
MC:VID
|
Spain | €901.35 Million |
|
Dashenlin Pharm Grp Co Ltd
SHG:603233
|
China | CN¥17.65 Billion |
|
Gold Road Resources Ltd
AU:GOR
|
Australia | AU$382.05 Million |
|
Companhia de Gás de São Paulo - COMGÁS
SA:CGAS3
|
Brazil | R$12.85 Billion |
|
Shanghai Hanbell Precise Machinery Co Ltd
SHE:002158
|
China | CN¥1.88 Billion |
|
Four Corners Property Trust Inc
NYSE:FCPT
|
USA | $1.29 Billion |
|
TAG Immobilien AG
F:TEG
|
Germany | €5.63 Billion |
Liability Composition Analysis (2000–2025)
This chart breaks down Viscofan's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see VIS market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.95 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.62 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.38 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Viscofan's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Viscofan (2000–2025)
The table below shows the annual total liabilities of Viscofan from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €504.10 Million ≈ $589.34 Million |
+8.66% |
| 2024-12-31 | €463.94 Million ≈ $542.39 Million |
+3.16% |
| 2023-12-31 | €449.74 Million ≈ $525.79 Million |
+2.09% |
| 2022-12-31 | €440.52 Million ≈ $515.02 Million |
+27.31% |
| 2021-12-31 | €346.02 Million ≈ $404.53 Million |
+13.75% |
| 2020-12-31 | €304.19 Million ≈ $355.63 Million |
+1.18% |
| 2019-12-31 | €300.64 Million ≈ $351.48 Million |
+8.88% |
| 2018-12-31 | €276.12 Million ≈ $322.81 Million |
+18.44% |
| 2017-12-31 | €233.12 Million ≈ $272.55 Million |
+4.58% |
| 2016-12-31 | €222.91 Million ≈ $260.61 Million |
+12.17% |
| 2015-12-31 | €198.72 Million ≈ $232.33 Million |
-33.99% |
| 2014-12-31 | €301.03 Million ≈ $351.94 Million |
+11.88% |
| 2013-12-31 | €269.06 Million ≈ $314.56 Million |
-3.56% |
| 2012-12-31 | €279.00 Million ≈ $326.18 Million |
+12.56% |
| 2011-12-31 | €247.86 Million ≈ $289.77 Million |
-12.36% |
| 2010-12-31 | €282.80 Million ≈ $330.63 Million |
+4.44% |
| 2009-12-31 | €270.78 Million ≈ $316.57 Million |
-7.64% |
| 2008-12-31 | €293.19 Million ≈ $342.77 Million |
+8.60% |
| 2007-12-31 | €269.97 Million ≈ $315.63 Million |
-7.22% |
| 2006-12-31 | €290.98 Million ≈ $340.18 Million |
+10.10% |
| 2005-12-31 | €264.29 Million ≈ $308.99 Million |
+29.53% |
| 2004-12-31 | €204.05 Million ≈ $238.55 Million |
+13.23% |
| 2003-12-31 | €180.21 Million ≈ $210.68 Million |
-14.33% |
| 2002-12-31 | €210.34 Million ≈ $245.91 Million |
-20.41% |
| 2001-12-31 | €264.28 Million ≈ $308.97 Million |
-99.43% |
| 2000-12-31 | €46.50 Billion ≈ $54.36 Billion |
-- |
About Viscofan
Viscofan, S.A., together with its subsidiaries, manufactures, produces, and distributes casings in Spain, Rest of Europe, Middle East, Africa, Pacific Asia, North America, South America, and internationally. The company offers cellulose, collagen, fibrous, functional solutions, plastics, viscofan veggie, efan, edileaf, nutra-pharma collinstant, nutra-pharma satiscoll, and medical. It also provide… Read more